AIDS

Skip Navigation LinksHome > March 31, 2000 - Volume 14 - Issue 5 > Factors associated with the successful modification of antir...
AIDS:
Clinical

Factors associated with the successful modification of antiretroviral therapy

Weidle, Paul J.a,b; Lichtenstein, Kenneth A.c; Moorman, Anne C.a; Bargen, Jennifer C. Vona; Greenberg, Kenneth S.c; Palella, Frank J. Jrd; Holmberg, Scott D.*; for the HIV Outpatient Study Investigators

Collapse Box

Abstract

Objectives: To assess the characteristics of medication regimen modification and the influence of a commercial genotypic resistance assay on the short-term (3–12 weeks) viral load response (≥ 0.5 log reduction) in HIV-1-infected patients extensively treated with antiretroviral therapy (ART).

Methods: A nested cohort study was performed in two clinics from the HIV Outpatient Study of 96 persons with a HIV-1 viral load of 104 log copies/ml or greater taking at least two antiretroviral medications.

Results: Successful modification was associated with adding at least two new medications [relative risk (RR), 1.5; 95% confidence interval (CI), 1.1–2.2], adding a drug from a previously unused class of agents (RR, 2.0; CI, 1.4–2.9), the initiation of a non-nucleoside reverse transcriptase inhibitor (NNRTI) (RR, 1.7; CI, 1.2–2.4), but not substituting a protease inhibitor or the use of a commercial genotypic resistance assay.

Conclusion: Incorporating a drug from a previously unused class or changing at least two new medications, but, within the confines of this study, not using a commercial genotypic resistance assay, was associated with the successful modification of ART as measured by a reduction in viral load.

© 2000 Lippincott Williams & Wilkins, Inc.

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.